|
|
|
41
|
A033AQ
|
GRANI-DENK 1MG/ML INJ (EDK) GRANISE (BQ)
|
GRANISETRON
|
GRANI-DENK
|
5X1ML
|
BQ
|
14.16
|
2.8325
|
VIAL
|
6
|
BOX
|
EDK
|
DENK PHARMA GMBH & CO. KG.
|
COL
|
COLLINS LTD
|
|
5622
|
ANTIEMETICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTIEMETICS
|
|
|
|
|
42
|
A033AQ
|
GRANI-DENK 1MG/ML INJ (EDK) GRANISE
|
GRANISETRON
|
GRANI-DENK
|
5X1ML
|
BQ
|
14.95
|
2.99
|
VIAL
|
6
|
VIAL
|
EDK
|
DENK PHARMA GMBH & CO. KG.
|
COL
|
AVENTA BARBADOS
|
|
5622
|
ANTIEMETICS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ANTIEMETICS
|
|
|
|
|
40
|
A033AW
|
GRANICIP 1MG/ML INJ (TPP/AHI) GRANISETRON
|
GRANISETRON
|
GRANICIP
|
3ML VIAL
|
BQ
|
6.25
|
6.25
|
INJECTION
|
0
|
VIAL
|
TPP
|
THERDOSE PHARMA PRIVATE LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5622
|
ANTIEMETICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
GASTROINTESTINAL DRUGS
|
|
|
|
|
41
|
A033AW
|
GRANICIP 1MG/ML INJ (TPP) GRANISETR (BQ)
|
GRANISETRON
|
GRANICIP
|
3ML VIAL
|
BQ
|
6.25
|
6.2521
|
VIAL
|
6
|
VIAL
|
TPP
|
THERDOSE PHARMA PRIVATE LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5622
|
ANTIEMETICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTIEMETICS
|
|
|
|
|
42
|
A033AW
|
GRANICIP 1MG/ML INJ (TPP) GRANISETR
|
GRANISETRON
|
GRANICIP
|
3ML VIAL
|
BQ
|
6.47
|
6.47
|
VIAL
|
6
|
VIAL
|
TPP
|
THERDOSE PHARMA PRIVATE LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5622
|
ANTIEMETICS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ANTIEMETICS
|
|
|
|
|
42
|
A033AX
|
GRANI-DENK 1MG/ML INJ (EDK) GRANISETRON
|
GRANISETRON
|
GRANI-DENK
|
5X1ML
|
BQ
|
14.95
|
2.99
|
AMPG
|
6
|
BOX
|
EDK
|
DENK PHARMA GMBH & CO. KG.
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
5622
|
ANTIEMETICS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ANTIEMETICS
|
|
|
|
|
40
|
A0411
|
CELLCEPT 500MG CAP (ROC/AHI) MYCOPHENOLATE
|
MYCOPHENOLATE
|
CELLCEPT
|
50'S
|
BQ
|
190.28
|
3.81
|
CAPSULE
|
0
|
CAP
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
A0411
|
CELLCEPT 500MG CAP (ROC) MYCOPHENOL (C)
|
MYCOPHENOLATE
|
CELLCEPT
|
50'S
|
C
|
190.28
|
3.8057
|
CAP
|
180
|
BOX
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
42
|
A0411
|
CELLCEPT 500MG CAP (ROC) MYCOPHENOL
|
MYCOPHENOLATE
|
CELLCEPT
|
50'S
|
BQ
|
190.28
|
3.81
|
CAP
|
180
|
BLIS
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
40
|
A0412
|
MYFORTIC 360MG CAP (NVS/COL) MYCOPHENOLATE
|
MYCOPHENOLATE
|
MYFORTIC
|
120'S
|
C
|
641.52
|
5.35
|
CAPSULE
|
0
|
CAP
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
A0412
|
MYFORTIC 360MG CAP (NVS) MYCOPHENOLATE (C)
|
MYCOPHENOLATE
|
MYFORTIC
|
120'S
|
C
|
641.52
|
5.346
|
CAP
|
240
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
41
|
A041L
|
APO-MYCOPHENOLATE 500MG TAB (APO) (BQ)
|
MYCOPHENOLATE
|
APO-MYCOPHENOLATE
|
50'S
|
BQ
|
51.02
|
1.0205
|
TAB
|
180
|
BOX
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
41
|
A041N
|
MYCOPHENOLATE 360MG TAB (INP) (C)
|
MYCOPHENOLATE
|
MYCOPHENOLATE
|
50'S
|
C
|
224.26
|
4.4852
|
TAB
|
0
|
BOX
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
41
|
A041Q
|
MOFILET 500MG TAB (EMC) MYCOPHENOLATE
|
MYCOPHENOLATE
|
MOFILET
|
60'S
|
BQ
|
61.98
|
1.033
|
TAB
|
180
|
BOX
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
IMMUNOSUPPRESSIVE AGENTS
|
2024-03-07
|
|
|
|
40
|
A0421
|
CELLCEPT 250MG CAP (ROC/AHI) MYCOPHENOLATE
|
MYCOPHENOLATE
|
CELLCEPT
|
100'S
|
BQ
|
190.28
|
1.90
|
CAPSULE
|
0
|
CAP
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
A0421
|
CELLCEPT 250MG CAP (ROC) MYCOPHENOL (C)
|
MYCOPHENOLATE
|
CELLCEPT
|
100'S
|
C
|
190.28
|
1.9028
|
CAP
|
360
|
BOX
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
42
|
A0421
|
CELLCEPT 250MG CAP (ROC) MYCOPHENOL
|
MYCOPHENOLATE
|
CELLCEPT
|
100'S
|
BQ
|
190.28
|
1.90
|
CAP
|
360
|
BLIS
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
40
|
A0422
|
MYFORTIC 180MG CAP (NVS/COL) MYCOPHENOLIC ACI
|
MYCOPHENOLIC ACID
|
MYFORTIC
|
120'S
|
C
|
320.76
|
2.67
|
CAPSULE
|
0
|
CAP
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
A0422
|
MYFORTIC 180MG CAP (NVS) MYCOPHENOLIC AC (C)
|
MYCOPHENOLIC ACID
|
MYFORTIC
|
120'S
|
C
|
320.76
|
2.673
|
CAP
|
240
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
41
|
A042G
|
APO-MYCOPHENOLATE 250MG CAP (APO) (BQ)
|
MYCOPHENOLATE
|
APO-MYCOPHENOLATE
|
100'S
|
BQ
|
51.02
|
0.5102
|
CAP
|
360
|
BOX
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
IMMUNOSUPPRESSIVE AGENTS
|
|